Northwestern Mutual Wealth Management’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-100
Closed -$1.23K 4373
2025
Q4
$1.23K Buy
+100
New +$1.63K ﹤0.01% 3592
2024
Q1
Sell
-3,109
Closed -$44.5K 3738
2023
Q4
$44.5K Buy
+3,109
New +$29.8K ﹤0.01% 2095
2023
Q3
Sell
-50
Closed -$715 3472
2023
Q2
$715 Buy
+50
New +$712 ﹤0.01% 3130

Other funds holding OPRX

Northwestern Mutual Wealth Management's OPRX Position: Q1 2026 in Review

Northwestern Mutual Wealth Management sold out of OptimizeRx (OPRX) in Q1 2026, closing a stake of 100 shares — an estimated $1.23K sold.

Northwestern Mutual Wealth Management first reported a position in OPRX in Q2 2023 and held it in 3 quarters. The position peaked at $44.5K in Q4 2023. 127 funds tracked by Wall St. Rank hold OPRX as of Q1 2026.

  • Northwestern Mutual Wealth Management reported no remaining OptimizeRx position as of Q1 2026 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 100 OptimizeRx shares in Q1 2026, an estimated $1.23K.
  • Northwestern Mutual Wealth Management first reported a position in OptimizeRx in Q2 2023 and held it in 3 quarters.
  • Northwestern Mutual Wealth Management's OptimizeRx position peaked at $44.5K in Q4 2023.
  • 127 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.